Litcius/Paper detail

Structure-activity relationship (SAR) studies of N-(3-methylpyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine (SRI-22819) as NF-ҡB activators for the treatment of ALS

Bini Mathew, Pedro Ruiz, Shilpa Dutta, Jordan Thomas Entrekin, Sixue Zhang, K.D. Patel, Micah Simmons, Corinne E. Augelli‐Szafran, Rita M. Cowell, Mark J. Suto

2020European Journal of Medicinal Chemistry11 citationsDOI

Topics & Concepts

ChemistrySOD1Context (archaeology)SOD2Superoxide dismutaseBiochemistryPharmacologyAntioxidantMedicinePaleontologyBiologyAmyotrophic Lateral Sclerosis ResearchBiochemical Acid Research StudiesCholinesterase and Neurodegenerative Diseases
Structure-activity relationship (SAR) studies of N-(3-methylpyridin-2-yl)-4-(pyridin-2-yl)thiazol-2-amine (SRI-22819) as NF-ҡB activators for the treatment of ALS | Litcius